L’anticorps Humanized Monoclonal anti-IL-6R (Tocilizumab Biosimilar) a été validé pour FACS et in vivo. Il convient pour détecter IL-6R (Tocilizumab Biosimilar) dans des échantillons de Humain.
N° du produit ABIN7795095
Aperçu rapide pour Recombinant IL-6R (Tocilizumab Biosimilar) anticorps (ABIN7795095)
Antigène
IL-6R (Tocilizumab Biosimilar)
Type d'anticorp
Recombinant Antibody
Reactivité
Humain
Hôte
Humanized
Clonalité
Monoclonal
Conjugué
Cet anticorp IL-6R (Tocilizumab Biosimilar) est non-conjugé
Application
Flow Cytometry (FACS), In vivo Studies (in vivo)
Classe de qualité
Research Grade
Expression System
Mammalian cells
Fonction
Tocilizumab Biosimilar, Human IL-6R Monoclonal Antibody
Attributs du produit
What is tocilizumab biosimilar research grade? Tocilizumab biosimilar uses the same protein sequences as the therapeutic antibody tocilizumab. Tocilizumab is a recombinant humanized monoclonal antibody IL-6 receptor inhibitor used to treat inflammatory and autoimmune conditions. Interleukin 6 (IL-6) is a pro-inflammatory cytokine produced by cells including T-cells, B-cells, lymphocytes, monocytes, fibroblasts. IL-6 rapidly induces C-reactive protein, serum amyloid A, fibrinogen, haptoglobin, and α-1-antichymotrypsin while inhibiting production of fibronectin, albumin, and transferrin. IL-6 also induces antibody production, induces cytotoxic T-cell differentiation, and inhibits regulatory T-cell differentiation. Tocilizumab binds soluble and membrane bound IL-6 receptors, preventing IL-6 mediated inflammation.